Focused on development and commercialization of antibiotics
Peninsula was acquired by Johnson & Johnson on June 30th 2005. Peninsula is a biopharmaceutical company focused on the development and commercialization of antibiotics to treat life threatening infections. The Company s mission is to develop optimal anti infective therapies that offer improved efficacy dosing and safety characteristics over existing therapies. In addition to DBL Investors investors include Canaan Partners and Domain Associates.
|Human health & social work||Operating|
Funding and Financing Rounds
Impact Reports & Metrics
1751 Harbor Bay Parkway
Alameda, California 94502
United States of America